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Abstract
After the United States, Spain comes second in the list of countries receiving migrants from
Latin America, and, therefore, it is the European country with the highest expected number
of infected patients of Chagas disease. We have studied the National Health System’s Hos-
pital Discharge Records Database (CMBD) in order to describe the disease evolution from
1997 to 2011 in Spain. We performed a retrospective descriptive study using CMBD infor-
mation on hospitalizations including Chagas disease. Data was divided in two periods with
similar length in time: 1997-2004 and 2005-2011. Hospitalization rates were calculated and
clinical characteristics were described. We used multivariable logistic regression to calcu-
late adjusted odds-ratio (aOR) for the association between various conditions and being
hospitalized with organ affectation. A total of 1729 hospitalization records were identified.
Hospitalization rates for the two periods were 18 and 242.8/100000 population, respective-
ly. The median age was 35 years (range 0-87), 74% were female and the 16-45 age-group
was mostly represented (69.8%). Overall, 23.4% hospitalizations included the diagnosis of
Chagas disease with organ complications. Being male [aOR: 1.3 (1.00-1.77)], aged 45 and
64 years [aOR: 2.59 (1.42-4.71)], and a median hospitalization cost above 3,065 euro
[aOR: 2.03 (3.73-7.86)] were associated with hospitalizations with organ affectation. Since
2005, the number of detected infections increased in Spain. The predominant patients’ pro-
file (asymptomatic women at fertile age) and the conditions associated with organ affecta-
tion underlines the need for increased efforts towards the early detection of T cruzi.
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Author Summary
Chagas disease, caused by the protozoa Trypanosoma cruzi, is endemic in most Latin
American countries and it is considered a neglected tropical disease (NTD). T. cruzi trans-
mission is feasible in vector-free world regions. The main non-vectorial routes are congen-
ital transmission, blood transfusion, and solid organ transplant. According to WHO, in
Spain, which is the second country in the world receiving migrant population from en-
demic countries, there are up to 40.000 persons at risk of developing symptomatic Chagas
disease. Since 2005, serological screening for at-risk blood and solid organ donors is man-
datory. Lately, some regulations regarding screening of pregnant women from Latin
American endemic countries have also been implemented, but only in some autonomous
regions. Up to date, there is no surveillance system in place. Thus, the Chagas disease bur-
den remains unknown. In this paper we use hospitalized Chagas disease discharge data, in
order to describe Chagas disease’s geographical and temporal trends before and after the
implementation of control measures in Spain from 1997 to 2011. We also assess patients’
main clinical characteristics by organ affectation.
Introduction
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening ill-
ness caused by the protozoan parasite, Trypanosoma cruzi (T. cruzi). This disease presents it-
self in two phases. The initial, acute phase lasts for about two months after infection. In most
cases, symptoms are absent or mild, but can include fever, headache, enlarged lymph glands,
pallor, muscle pain, difficulty in breathing, swelling and abdominal or chest pain [1,2]. Dur-
ing the chronic phase, the parasites are hidden mainly in the heart and digestive muscle. Up
to 30% of patients suffer from cardiac disorders (sudden death, complex arrhythmias, ven-
tricular aneurysms, heart failure, and thromboembolism) and up to 10% suffer from digestive
(typically enlargement of the esophagus or colon), neurological or mixed alterations [3]. In
later years the infection can lead to sudden death or heart failure caused by progressive de-
struction of the heart muscle [1]. Chagas disease can be effectively treated with benznidazole
and also nifurtimox. Both drugs are almost 100% effective in curing the disease if given soon
after infection at the onset of the acute phase [4]. However, the efficacy of both diminishes
the longer a person has been infected, thus the importance of an early diagnosis [5]. Addi-
tionally, specific treatment for cardiac or digestive manifestations may be required at latest
stages of the infection [6].
Worldwide, between seven and eight million people are estimated to be infected with Cha-
gas. The disease is endemic in 21 Latin American countries [7], where it is mostly transmitted
to humans through the bite of the triatomine bug, Chagas disease natural reservoir [8]. Never-
theless, T. cruzi transmission is also possible in vector-free world regions [9]. The main non-
vectorial routes are congenital transmission, blood transfusion, and solid organ transplant,
these routes being characteristics but not exclusive to non-endemic countries [10].
Although most of the cases occurr in Latin America [11], Chagas disease in non-endemic
countries, such as North America and the Western Pacific Region (mainly Australia and
Japan), has come to light since the beginning of 2000, and only more recently in Europe [12].
In 2010, the World Health Organization (WHO) estimated that 80.000 persons could be in-
fected in Europe, making Chagas disease one of the predominant emerging parasitic infections
in the Old World [13].
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The emergence of the disease in non-endemic countries is mainly linked to population mo-
bility, notably migration from endemic countries [12]. Beginning with 2010, Spain had the
highest immigration rates from Latin America within the EU, (second after the USA world-
wide) [14]. A study published by the European Center for Disease Prevention and Control
(ECDC) estimated that in 2009, 53% (more than 1.7 million people) of the European migrant
population coming from Latin America were living in Spain [15]. The same study indicated
Spain as the country with the highest prevalence of Chagas disease in migrant population from
endemic countries (2.3–3.8%). Estimates that take into account the prevalence of T. cruzi infec-
tion in Latin America suggest that between 40,000 and 65,000 infected people currently reside
in Spain [16].
In the last decade some progress has been made regarding the management of Chagas disease
in Spain. Since September 2005, in accordance with the Royal Decree RD1088/2005, serological
screening of the population considered to be at risk is mandatory in all blood transfusion centers
[17]. Regulations regarding screening of pregnant women from Latin American endemic coun-
tries and their newborns are in place in 4 out of 17 autonomous regions (Valencia, Catalonia,
Galicia and Basque Country) [18–21]. In the rest of the country, the detection of congenital
Chagas cases depends mainly on the initiative of the health professionals of the National Health
System [15] (Table 1).
Up to date, there is no surveillance system for Chagas disease implemented in Spain. How-
ever, hospitalized cases are recorded within the National Health System0s Hospital Discharge
Records Database (CMBD in Spanish) belonging to the Spanish Ministry of Health. In this
paper, we describe for the first time the Chagas disease related hospitalizations in Spain be-
tween 1997 and 2011, in terms of time, geographical distribution, and disease related
individual characteristics.
Methods
We performed a retrospective descriptive study using CMBD information on Chagas disease
related hospitalizations in Spain between January 1st, 1997 and December 31st, 2011. CMBD
database receives notification from around 98% of the public hospitals in Spain [22]. Compul-
sory health insurance covers an estimated 99.5% of the Spanish population, although persons














Catalonia 2010 Yes *
Galicia 2012 Yes *
Madrid1 2008 No * *
Murcia2 2006 No *
2013 Yes *




1 Hospitals network screening protocol: testing of the other children of an infected mother.
2 Immigrant children health care protocol: testing of Bolivian children with positive family history of Chagas disease.
3 Recommendations for migrant adult healthcare: Testing of migrants from endemic countries in case of Chagas disease symptomatology, HIV infection,
pregnancy with Chagas symptoms (clinical or EKG).
doi:10.1371/journal.pntd.0003710.t001
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not covered by health insurance can receive treatment in public hospitals. Since 2005, CMBD
also has a gradual coverage from private hospitals [23].
All CMBD’s hospital discharges having included the Chagas disease diagnosis were reviewed,
in any of 14 possible diagnostic positions. For each entry, we collected socio-demographic (sex,
age and autonomous region of residency) and clinical data (type and department of admission,
average length of hospitalization, non-invasive procedures and history of surgical intervention
during the hospitalization, re-admission, outcome, hospitalization0s cost to the health care sys-
tem, financing regime and diagnosis related group (DRG). Other concurrent clinical diagnoses,
in any of the 14 positions, were also assessed. International Classification of Diseases, Ninth Re-
vision, Clinical Modification (ICD 9 CM) were used for this purpose [24].
We calculated the hospitalization rates by sex and autonomous regions using as denomina-
tors the Latin American officially registered population in Spain from the 21 countries endemic
for Chagas disease. Latin American population figures were available since 1998 from the
Spanish National Institute of Statistics (INE) website [25]. The rates increase among the two
study periods (1998–2004 and 2005–2011) were mapped using the Geographical Information
System Arcgis version 10.0.
We described the clinical characteristics separately for: a) all hospitalizations, regardless
the Chagas diagnosis position; b) hospitalizations with Chagas as first diagnosis and;
c) hospitalization with child delivery related stay as first diagnosis. For all hospitalizations,
we also examined the differences between the patients notified with Chagas disease with and
without an organ (heart or digestive system) complication. We assessed the group distribu-
tion by using chi-squared and Fischer exact test, when needed, and evaluated the association
level between organ complication and clinical individual risk factors through univariate anal-
ysis. We included the risk factors for being hospitalized having Chagas disease and a form of
organ affectation with a statistically significant association (p<0.1) in a multivariable logistic
regression model (backward stepwise procedure), in order to control for possible confound-
ers. Data analysis was performed using STATA software version 12.
Ethics Statement
This study involves use of patient medical data from The Spanish National Hospital Database
(CMBD). These data, are hosted by the Ministry of Health Social Services and Equality
(MSSSI). Researchers working in public and private institutions can request the databases by
filling, signing and sending a questionnaire available at the MSSSI website. In this question-
naire a signed Confidentiality Commitment is required. All data is anonymized and de-identi-
fied by the MSSII before it is provided to applicants. According to this Confidentiality
Commitment signed with the MSSSI, researchers cannot provide the data to other researchers,
thus other researchers must request the data directly to the MSSSI [22].
Results
Distribution of Hospitalization Related to Chagas by Time and
Autonomous Region
Between 1997 and 2011, 1729 hospitalizations including Chagas disease in any diagnosis position
were recorded in Spain, out of which 546 (31.6%) were re-admissions. Up to 90% (1630/1729) of
these cases were notified between 2005 and 2011. For the two study periods (1998–2004 and
2005–2011), we obtained hospitalization rates of 18 and 242.8/100000 population, respectively.
While the Latin American population migrating form Chagas disease endemic countries
began to increase steadily from 2001, the hospitalization rate showed a stationary tendency in
Chagas Disease Hospital Discharges in Spain
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the first time period. In the second time interval (2005–2011), this rate increased while the
Latin American population began a slow decrease, starting with 2009 (Fig 1). The increase in
hospitalization rate was registered in all but two autonomous regions (Fig 2 and S2 Table). For
eight autonomous regions the hospitalization rate increased more for women, in two increased
more for men, while in seven autonomous regions there was no difference among sexes (Fig 3).
Clinical Characteristics of Chagas Related Hospitalizations
The median age of the 1729 hospitalizations was 35 years (range 0–87) with the 16–45 age-
group being mostly represented with 1207/1729 (69.8%). A total of 74% hospitalized were fe-
male, predominating in all age-groups (Fig 4). For 206/1729 (11.9%) records, Chagas disease
was registered as the first diagnosis while for 878/1729 (50.7%) appeared as second diagnosis.
Other diagnoses in first position are summarized in S1 Table. In the remaining 37.4% records,
Chagas disease appeared in any of the last 12 positions. The most frequent main diagnostics as-
sociated with Chagas disease were related to pregnancy, giving birth or postpartum complica-
tions (36.6%), heart and circulatory conditions (15.3%) and digestive system conditions (9.1%).
The hospital departments with higher number of Chagas related admissions were Obstetrics-
Gynecology (37.1%), Cardiology (13.1%), Internal Medicine (11.2%) and Digestive Diseases
(7.9%) (S3 Table). Overall, 1302/1792 (75.3%) hospitalizations were related to Chagas disease
without organ complications, while 388/1792 (23.4%) hospitalizations were recorded as Chagas
disease with organ complications, of which 317/388 (81.7%) were due to heart complications
and 71/388 (17.9%) were due to another organ complications. Invasive or non-invasive medical
procedures were documented for 1463/1729 (84.6%) hospitalizations. We identified 290 differ-
ent types of medical procedures; 579/1463 (33.5%) procedures were related to obstetrical sur-
gery, 375/1463 (21.7%) were diagnosis or therapy procedures and 190/1463 (11%) were related
to heart surgery. Of the total 1729 hospitalizations, 487 (28.2%) had registered a surgical inter-
vention. The admission period was inferior to one week in 71% of Chagas related hospitaliza-
tions. The predominant admission type was urgent (76.6%) and 61.5% had a severity level of 2
(out of 4). Around 95% of them were discharged at home, decease occurring in 1.2% of overall
Fig 1. Immigrant population coming from Chagas disease endemic countries and Chagas related
hospitalization rates 1998–2011, Spain.
doi:10.1371/journal.pntd.0003710.g001
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Fig 2. Increase in Chagas disease hospitalization rates by region between 1998–2004 and 2005–2011, Spain (times).
doi:10.1371/journal.pntd.0003710.g002
Fig 3. Increase in Chagas disease hospitalization rate by region and sex between 1998–2004 and 2005–2011 by sex, Spain (times).
doi:10.1371/journal.pntd.0003710.g003
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Chagas related hospitalizations. The hospitalization median cost was 3,064.9 euros (range
287.3–939,324.1). Costs were covered by social security health care service for 95% of the cases
(Table 2).
Chagas Disease as First Diagnosis
A total of 55.6% (114/206) hospitalized were female, with the 16–45 and 46–65 age-groups
being mostly represented (49.3% and 32.7%, respectively). Around 50% of the hospitalizations
were related to Chagas disease with organ complication. Surgical intervention was docu-
mented for 25/206 (12.2%) hospitalizations and invasive or non-invasive medical procedures
were documented for 147/206 (71.4%) hospitalizations. The predominant admission type was
urgent (58.5%) followed by programmed (41.5%). Median time of hospitalization was 7 days,
and up to 40% stayed more than one week. Around 90% (184/206) were discharged at home;
decease occurred in 2.4% of these hospitalizations. The hospitalization median cost was
4195.6 euros.
Child Delivery as First Diagnosis
From 1997 to 2011, 614 hospitalizations related to Chagas disease with child delivery as first di-
agnosis occurred. The 16–45 age-group was predominant with 612/614 (99.7%) and heart and
other organ complications were present in 23/614 (3.8%) and 4/614 (0.6%) of these hospitaliza-
tions, respectively. Surgical intervention was recorded for 43.8% of them, and they were mostly
urgent admissions (93.2%). Invasive or non-invasive medical procedures were documented for
all the hospitalizations, mainly obstetrical procedures. Up to 95% stayed less than one week in
the hospital, being the median average time of 3 days. Around 99% hospitalizations were dis-
charged at home, only 30/614 (4.9%) need to be re-admitted. The hospitalization median cost
was 2,207.9 euros.
Fig 4. Distribution of Chagas disease related hospitalization by sex, Spain, 1998–2011.
doi:10.1371/journal.pntd.0003710.g004
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Table 2. Clinical characteristics of all hospitalizations (n = 1729), hospitalizations including Chagas disease as first diagnosis (n = 206) and hospi-
talizations including child delivery as first diagnosis (n = 614), Spain 1997–2011.
Hospitalizations including Chagas disease diagnostic
Variables Chagas disease at any
diagnostic position
(n = 1729)
Chagas disease as first
diagnosis (n = 206)
Child delivery as first
diagnosis (n = 614)
n % n % n %
Sex
Male 450 26.03 92 44.88 N.A. N.A.
Female 1279 73.97 114 55.61 614 100
Age
5 years 86 4.97 21 10.24 N.A. N.A.
6–15 years 10 0.58 4 1.95 1 0.16
16–45 years 1207 69.81 101 49.27 612 99.67
46–65 years 363 20.99 67 32.68 1 0.16
66 years 63 3.64 13 6.34 N.A. N.A.
Chagas disease type
Without organ affectation 1302 75.30 77 37.56 587 95.60
With heart complication 317 17.29 89 43.41 23 3.75
With other organ complication 71 4.11 34 16.59 4 0.65
Heart and other organ complication 18 1.04 1 0.49 0 0
Unknown 39 2.26 5 1.95 0 0
Surgical intervention history
No 1242 71.83 181 88.29 345 56.19
Yes 487 28.17 25 12.20 269 43.81
Admission type
Urgent 1316 76.11 120 58.54 572 93.16
Programed 403 23.31 85 41.46 42 6.84
Unknown 10 0.58 1 0.49 0 0
Discharge type
Home 1652 95.55 184 89.76 611 99.51
Other 56 3.24 17 8.29 3 0.49
Deceased 21 1.21 5 2.44 0 0
Re-admission
No 1183 68.42 118 57.07 584 95.11
Yes 546 31.58 88 42.93 30 4.89
Hospitalization time
<one week 1233 71.32 114 55.6 585 95.28
>one week 457 26.43 91 45.4 29 4.72
Costs covered by social security health care
No 87 5.03 15 7.28 27 4.40
Yes 1642 94.97 191 92.72 609 95.60
Variable Median Range Median Range Median Range
Hospitalization time (days) 4 0–231 7 0–231 3 1–27
Hospitalization cost (euro) 3,064.9 939,036.78 4,195.62 41,8549.38 2,207.86 376,733.68
doi:10.1371/journal.pntd.0003710.t002
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Conditions Associated with Chagas Disease with Organ Complications
Through bivariate analysis, we identified several conditions associated with hospitalization due
to Chagas disease with organ affectation. Being male, aged over 45 years, Chagas disease as
main diagnosis, a history of re-admission in the hospital, and hospitalization’s cost higher than
the median (3,065 euros), were significantly associated with Chagas disease with organ affecta-
tion. On the other hand, being aged between 16 and 45 years, hospitalization stay up to one
week, a history surgery, the urgent admission type and the medium level of disease severity
where inversely associated with organ affectation (Table 3).
All these significant variables where included in the final multivariable logistic regression
model. Results indicated that the patients being hospitalized with organ affectation Chagas dis-
ease were 1.3 times more likely to be male, 2.6 times more likely to be aged between 45 and 64
years, 5.4 times more likely to be admitted with Chagas disease as main diagnosis, and almost 3
times more likely to be admitted for the first time in the hospital, compared to those admitted
with Chagas disease without organ affectation. Also, hospitalizations with organ affectation
were two times more likely to cost above the median cost of 3065 euro that the hospitalizations







unadjusted OR p value adjusted OR p value
n % n %
Sex Male 160 41.20 278 21.30 1 0.000 1 0.048
Female 228 58.80 1,024 78.70 2.58 (2.02–3.29) 0.000 1.33 (1.00–1.77) 0.048
Age group 5 23 5.93 58 4.45 1 1 1
6–15 0 0.00 10 0.77 − − − −
16–45 177 45.62 1,003 77.04 0.44 (0.27–0.74) 0.002 0.97 (0.54–1.72) 0.916
46–65 159 40.98 199 15.28 2.01 (1.19–3.41) 0.009 2.59 (1.42–4.71) 0.002
66 29 7.47 32 2.46 2.29 (1.14–4.59) 0.020 2.57 (1.19–5.54) 0.010
Chagas as first diagnosis Yes 128 33.00 77 5.90 1 0.000 1 0.000
No 260 67.00 1,225 94.10 7.83 (5.72–10.7) 0.000 5.42 (3.73–7.86) 0.000
Hospitalization time 1 week 224 57.70 1,009 77.50 1 0.000 1 N.S.
>1 week 164 42.30 293 22.50 0.40 (0.31–0.50) 0.000 N.S. N.S.
Surgical intervention Yes 59 15.20 417 32.00 1 0.000 1 0.003
No 329 84.80 885 68.00 0.38 (0.28–0.51) 0.000 0.58 (0.41–0.83) 0.003
Re-admission Yes 51 13.10 106 8.10 1 0.000 1 0.000
No 337 86.90 1,196 91.90 4.00 (3.16–5.07) 0.000 2.86 (2.17–3.78) 0.000
Admission type Urgent 263 68.10 1022 79.00 1 0.000 1 N.S.
Planned 123 31.90 272 21.00 0.57 (0.44–0.73) 0.000 N.S. N.S.
Deceased Non-exitus 380 97.94 1289 99.00 1 0.101 1 N.S.
Exitus 8 2.06 13 1.00 2.10 (0.87–5.12) 0.101 N.S. N.S.
Hospitalization cost 3,064.9 91 23.50 745 57.20 1 0.000 1 0.000
>3,064.9 297 76.50 557 42.80 4.24 (3.28–5.48) 0.000 2.03 (1.49–2.78) 0.000
Severity level 0–1 69 17.8 111 8.50 1 1
2 173 44.6 871 66.90 0.32 (0.23–0.45) 0.000 0.46 (0.3–0.7) 0.001
3–4 146 37.6 320 24.60 0.73 (0.51–1.05) 0.091 0.73 (0.46–1.15) 0.176
N.S.- Non significant; Goodness of fit: AIC = 1389.17; Pseudo R2 = 0.24;
doi:10.1371/journal.pntd.0003710.t003
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of asymptomatic Chagas disease. Not having a personal surgery history and medium severity
level appeared to have a negative association with Chagas disease with organ affectation
(Table 3).
Discussion
Although there are few studies performed locally in Spain [16,26,27], to our knowledge, this is
the first one addressing Chagas disease epidemiology nationwide. Moreover, the use of hospi-
talized data for characterizing Chagas disease epidemiology in non-endemic countries also rep-
resents a premier. We relied on a database providing information from a net of hospitals that
covers more than 98% of the population living in Spain [24], therefore we belief that our results
are representative for the Spanish territory.
We aimed to describe the Chagas disease epidemiology between 1998 and 2011 in Spain. As
CMBD do not provide enough information that would allow for differentiation between T.
cruzi infection and Chagas disease, we have chosen the second one as term for our discussion.
We have observed an overall increase in hospitalizations including Chagas disease, beginning
with 2005 (Fig 3). This occurs while the figures for Latin American migrant population from
countries endemic to Chagas were increasing in the 2000–2004 period, but become stable after
2005. This increase in hospitalizations that includes Chagas disease might be due to the intro-
duction in 2005 of the national program for controlling the Chagas disease horizontal trans-
mission (blood and organ donors screening). Another explanation might surge from the
implementation of screening programs for pregnant women. However, it is difficult to quantify
the impact of these measures over the hospitalization rate. Community of Valencia in 2007
[18], Catalonia in 2010 [19,28], Galicia in 2012 [20], Basque Country in 2008 [21] and more re-
cently Murcia in 2013 [29] (5 out of 17) have implemented protocols for screening and diagno-
sis of T. cruzi infection in pregnant women in order to allow for early diagnostic and infection
treatment in newborns. The hospitalization rates increased more for women in Basque coun-
try, Murcia and Valencian Community, while the increase0s rates were higher in men in Cata-
lonia and similar for both sexes in Galicia. In the Basque Country the recommendation for
screening pregnant women from endemic countries includes only those women with clinical
symptoms or EKG modifications [21]. Protocols also exist in other autonomous communities,
but their implementation is confined only to certain hospitals. This is the case of Madrid [30]
and Murcia (before the implementation of the regional screening in 2013) [31]. These proto-
cols are heterogeneous in terms of target population as well as the region coverage and the year
of implementation (Table 1).
Otherwise, the number of hospitalizations has also increased in those communities without
official screening practices and/or regulations in place for pregnant women. Increased aware-
ness of Chagas disease in both healthcare professionals and patients and relatives might be a
possible explanation for this trend. It is also feasible that local initiatives towards early diagno-
sis of Chagas disease might exist in other autonomous regions, these actions remaining un-
known at central level. It remains however unclear why in two communities the overall
hospitalization rate decreased in 2005–2011 compared to 1998–2004.
Our study indicates that most of the hospitalizations which included Chagas disease diagno-
sis at any position were females. Nevertheless, the percentage of female sex decreased from
74% to 55.6% when we analyzed only those hospitalizations with Chagas disease as first diag-
nosis. Another striking feature is the age-group, as most of the female cases were aged between
16–45 years, while the immigrant population distribution in Spain, reveals however uniformity
between sexes [32]. Similar findings were described in another Spanish study on patients with
Chagas disease attending the hospital care [33]. This can have several explanations: according
Chagas Disease Hospital Discharges in Spain
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to the Spanish Institute of Statistics, the migrant Latin American women are predominant in
Spain, the 16–45 age-group corresponding to the most well represented age group, with more
than 70% being aged between 15 and 45 years [25]. Additionally, screening programs targeting
pregnant women implemented in the above mentioned autonomous communities could repre-
sent an alternative explanation for the high percentage of hospitalized women at fertile age.
This is concordant with a previous estimation indicating that women at childbearing age repre-
sent more than 60% of the overall estimated T. cruzi infections in Spain [10]. This finding sup-
ports even more the need of extended screening for pregnant women coming from Latin
American countries endemic for Chagas. On the other hand, when we assessed only those hos-
pitalizations with Chagas disease as first diagnosis (n = 206), the 16–45 years old group remain
the most frequent (49.3%), but closely followed by the 46–65 years old (32.7%). These figures
are similar with the Chagas’ disease prevalence rates provided by WHO Global burden of Cha-
gas’ disease estimations [34].
The most important aspect in Chagas disease evolution is represented by the heart or digestive
system affectation, secondary to prolonged T. cruzi infection. In our study, the percentage of the
reports with cardiac or digestive affectation was around 22%. Of these hospitalizations, the ma-
jority had developed a Chagas related cardiac chronic condition. These figures are concordant
with a previous estimate of potentially infected immigrants in Spain [10,35]. On the other hand,
the high percentage of diagnosed asymptomatic T.cruzi in our study (77%) could be seen as due
to implementation of nationwide and local screening programs. These is however difficult to
prove. The analyzed database do not registers information related to the reason of testing for T.
cruzi existence. Moreover, the rates of symptomatic Chagas disease increase to 50% when we as-
sess only those hospitalizations with Chagas disease as first diagnosis, the heart being the main
affected organ. This supports our hypothesis and also bring to light that Chagas disease could be
consider a reason for hospitalization, even if organic complications do not exist. A possible expla-
nation might be that these hospitalizations are related with diagnostic procedures. In fact, 74% of
these hospitalizations include invasive or non-invasive medical procedures.
The majority of hospitalizations (1524/1729) didn’t have Chagas disease recorded as the
main diagnosis; therefore one could consider that even though Chagas disease was present as
pathology, it was not the main reason for hospital admission. Almost half of the hospitaliza-
tions with Chagas disease as main principal diagnosis had documented chagasic heart condi-
tion and another 17% other organ affectation. On the other hand, for the reports where Chagas
is not the main diagnosis, 82% had documented asymptomatic Chagas disease. Moreover, less
than 5% of the hospitalizations with child delivery as first diagnosis include Chagas disease
with any organ complication. Therefore one could speculate that unless the T. cruzi has evolved
into a chronic condition, it represents most of the time a silent disease and can easily go under-
diagnosed if not properly searched for. This again stresses the importance of developing effi-
cient strategies for an early T.cruzi detection, even more when considering that the efficacy of
Chagas disease drugs diminishes the longer a person has been infected [4].
History of surgical intervention was especially prevalent in child delivery hospitalizations,
probably related to the delivery itself, as it occurred with the admission type, most commonly
urgent in this kind of hospitalizations. On the other hand, hospitalizations with Chagas disease
as first diagnosis stayed longer in the hospital than those where it was placed at any position or
where child delivery was listed at first diagnosis. Moreover, we saw that the percentage of
deaths was slightly higher in those reports with Chagas disease as first diagnosis. We know that
Chagas disease is a major cause of mortality in Latin America due to a wide range of pathogenic
processes [36]. Our results might suggest higher severity (and probably more symptomatic) if
Chagas is placed as first diagnostic, however this is difficult to prove. The analyzed database do
not registers information related to the cause of death. Finally, the median cost was 37% and
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90% more in hospitalizations with Chagas disease as first diagnosis compared to records with
Chagas diseases in any diagnostic position and delivery as first diagnosis, respectively. This
finding suggests that the expansion of the screening program and other prevention activities
might be a good public health policy in concept of saving costs.
We have identified the male gender as being associated with Chagas disease involving organ
affectation. The association was borderline significant, indicating a possible similarity between
genders when it comes to chronic Chagas disease. Reports on sex differences in progressive Cha-
gas’ disease are controversial and previous studies have found either that it is more common in
men or that it is unrelated to sex [37]. Eventually, selective preventive measure such as Chagas
screening only and exclusively in pregnant women might also result in gender differences.
The association of the 45–64 years age-group with Chagas disease with organ affectation is
concordant with previous knowledge related to a 20–30 years of asymptomatic infection be-
tween contracting the infection and developing the chronic form [38]. Also reports relating
Chagas disease with organ conditions were associated with having Chagas disease as main di-
agnosis and being hospitalized for the first time. Chagas disease associated to an organ condi-
tion was 2 times more likely to have a hospitalization cost above the median value than those
without organ complications, this finding being especially relevant from a public health per-
spective for Spain. The cost could be even higher if one is considering the indirect costs related
to work absenteeism, incapacity, etc. This might be also the case in any non-endemic country
with important immigration from Latin America. Sicuri et al. indicated in their economic eval-
uation of Chagas disease screening in Catalonia, that targeting all Latin American women giv-
ing birth in Spain and of their infants is the best strategy compared to the non-screening
option, showing not only obvious economic advantages but also providing useful information
for health policy makers in their decision making process [39].
Limitations and Conclusions
We calculated the hospitalization rate using as denominators Latin American immigrants offi-
cially registered in Spain. Non-registered immigrants could enlarge both the population de-
nominator and the number of cases, thus the results should be interpreted with caution.
Another limitation when using the CMBD database is that the country of origin is not re-
corded, therefore the hospitalization rates can be calculated only as overall figures. This is an
important aspect being known that the endemicity levels varies widely among Latin American
countries [40]. On the other hand, the estimation of the risk factors for hospitalizations with
organ complications might be influenced by this and other factors not present in the
CMBD database.
One of the strong points of CMBD is that it provides the total number of hospitalizations
records without being subject to the limitations of outpatient surveillance systems, such as
under-diagnosis or reporting deficiencies. It remains dependent only by the population’s health
seeking behavior and healthcare accessibility. The Spanish Government enacted a Royal Decree
in 2012 which basically limits access to free services at the point of delivery for all population
(including non-residents migrants), undermining the principle of universal coverage which
exist in this country since 1986 [41]. This can have as consequence a decrease in the number of
Latin American immigrants attending to the healthcare services. Subsequently, and in the ab-
sence of systematic and coordinated actions towards early detection of T. cruzi, a larger number
of asymptomatic infections might remain under-diagnosed, increasing the number of patients
suffering from Chagas disease chronic conditions in the future.
In conclusion, using hospitalized cases discharge database can be a useful tool when describ-
ing the Chagas disease epidemiology. However, our work underlines the need of a nationwide
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systematic approach towards T. cruzi early detection, especially targeting fertile aged women
and relatives from endemic Latin American countries. Health inequalities on immigrants
health status might exist across our country if screening programs differ from one region to an-
other and, furthermore, are not nationwide implemented. Moreover, a national surveillance
system that would allow a more accurate data collection, analyzing and interpretation, could be
of added value in completing a more accurate picture of Chagas disease in Spain, resulting use-
ful both in gaining extended disease knowledge, but especially in evaluating implemented
control actions.
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